Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

If you liked this article you might like

10 Biotech Stocks With A History Of Beating Earning Expectations

10 Biotech Stocks With A History Of Beating Earning Expectations

Breaking Up With Gilead Sciences

Breaking Up With Gilead Sciences

The Long YM Bio Nightmare Has Ended -- Happily.

The Long YM Bio Nightmare Has Ended -- Happily.

Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena

Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena